x
Filter:
Filters applied
- Genomics and Proteomics
- Yang, YanyanRemove Yang, Yanyan filter
Publication Date
Please choose a date range between 2019 and 2020.
Keyword
- nucleotide excision repair3
- DNA damage2
- excision repair sequencing (XR-Seq)2
- transcription-coupled repair (TCR)2
- antibiotic resistance1
- chemoresistance1
- chemotherapy1
- Cockayne syndrome WD repeat protein (CSA)1
- colorectal cancer1
- CSB1
- cyclobutane pyrimidine dimers1
- cytotoxicity1
- DNA repair1
- DNA transcription1
- Drosophila1
- drug resistance1
- Mfd1
- Mycobacterium smegmatis1
- Mycobacterium tuberculosis1
- Rad261
- Rad281
- RNA polymerase II1
- UV DNA damage1
- UvrC1
- UvrD1
Genomics and Proteomics
3 Results
- Accelerated CommunicationsOpen Access
Mycobacteria excise DNA damage in 12- or 13-nucleotide-long oligomers by prokaryotic-type dual incisions and performs transcription-coupled repair
Journal of Biological ChemistryVol. 295Issue 50p17374–17380Published online: October 21, 2020- Christopher P. Selby
- Laura A. Lindsey-Boltz
- Yanyan Yang
- Aziz Sancar
Cited in Scopus: 5In nucleotide excision repair, bulky DNA lesions such as UV-induced cyclobutane pyrimidine dimers are removed from the genome by concerted dual incisions bracketing the lesion, followed by gap filling and ligation. So far, two dual-incision patterns have been discovered: the prokaryotic type, which removes the damage in 11–13-nucleotide-long oligomers, and the eukaryotic type, which removes the damage in 24–32-nucleotide-long oligomers. However, a recent study reported that the UvrC protein of Mycobacterium tuberculosis removes damage in a manner analogous to yeast and humans in a 25-mer oligonucleotide arising from incisions at 15 nt from the 3´ end and 9 nt from the 5´ end flanking the damage. - DNA and ChromosomesOpen Access
Genome-wide single-nucleotide resolution of oxaliplatin–DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines
Journal of Biological ChemistryVol. 295Issue 22p7584–7594Published online: April 16, 2020- Courtney M. Vaughn
- Christopher P. Selby
- Yanyan Yang
- David S. Hsu
- Aziz Sancar
Cited in Scopus: 11Platinum-based chemotherapies, including oxaliplatin, are a mainstay in the management of solid tumors and induce cell death by forming intrastrand dinucleotide DNA adducts. Despite their common use, they are highly toxic, and approximately half of cancer patients have tumors that are either intrinsically resistant or develop resistance. Previous studies suggest that this resistance is mediated by variations in DNA repair levels or net drug influx. Here, we aimed to better define the roles of nucleotide excision repair and DNA damage in platinum chemotherapy resistance by profiling DNA damage and repair efficiency in seven oxaliplatin-sensitive and three oxaliplatin-resistant colorectal cancer cell lines. - Accelerated CommunicationsOpen Access
Drosophila, which lacks canonical transcription-coupled repair proteins, performs transcription-coupled repair
Journal of Biological ChemistryVol. 294Issue 48p18092–18098Published online: October 17, 2019- Nazli Deger
- Yanyan Yang
- Laura A. Lindsey-Boltz
- Aziz Sancar
- Christopher P. Selby
Cited in Scopus: 20Previous work with the classic T4 endonuclease V digestion of DNA from irradiated Drosophila cells followed by Southern hybridization led to the conclusion that Drosophila lacks transcription-coupled repair (TCR). This conclusion was reinforced by the Drosophila Genome Project, which revealed that Drosophila lacks Cockayne syndrome WD repeat protein (CSA), CSB, or UV-stimulated scaffold protein A (UVSSA) homologs, whose orthologs are present in eukaryotes ranging from Arabidopsis to humans that carry out TCR.